The COVID-19 cases are increasing day by day all around the world. There are around 13.1 million confirmed cases and around 5,270,696 are active cases. There are countries that are worst hit and also that have contained the spread of corona.
At such times all we can do is stay safe unless the vaccine is invented. Speaking of which, the Russia corona vaccine is claimed to be the first-ever vaccine clearing clinical trial safely. The vaccine is being developed by Sechenov University.
The first clinical trial on the volunteers at Sechenov First Moscow State Medical University was completed successfully on 12th July 2020. Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology said the first group of the volunteers is going to get discharged on July 15th and the second group on July 20th.
The trial started on 18th of June, the first group had 18 volunteers and the second one had 23, they were given the dosage in liquid form as well as the powdered form, and were kept in isolation in order to save them from any other infection.
Phase I was successful for the Russia COVID 19 vaccine. Phase II trials were started on July 13th, once it clears the Phase II safely without any side effects it will move towards the Phase III human trials. (There’s no information on when Phase III trials will begin.)
As for its safety concern, Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases at Sechenov University told Russian media agency that, “The safety of the vaccine is confirmed. It corresponds to the safety of those vaccines that are currently on the market, the further vaccine development plan is already being determined by the developer’s strategy, including the complexity of the epidemiological situation with the virus and the possibility of scaling up production.”
Once all phases of the coronavirus vaccine human trial are successful, then only it will be commercially available for the use of the public. Also, if it clears all the stages, then Russia will become the first to develop the coronavirus vaccine.
Till then you will have to stay safe, many pharma companies have developed medicine to help the patients recover, and around 135 potential vaccines are at a preclinical stage. 23 vaccines are in the human trial phase of which 15 candidates are at Phase I trial.
For more updates on coronavirus cases and vaccines, Visit HealthClubFinder.